1 result for "MINDSET PHARMA INC."
Add this URL to any RSS reader. Updated daily.
MindSet Pharma Indole Derivative Serotonergic Patent Granted
USPTO granted patent US12606543B2 to MindSet Pharma Inc. on April 21, 2026. The patent covers indole derivatives as serotonergic agents useful for activation of serotonin receptors in cells and treating diseases, disorders, or conditions including psychosis, mental illnesses, and CNS disorders.
Routine
Notice
Intellectual Property
Get alerts for "MINDSET PHARMA INC."
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
73
AI Regulation
3
Banking & Finance
412
Consumer Protection
89
Courts & Legal
411
Data Privacy & Cybersecurity
90
Defense & National Security
53
Education
55
Energy
100
Environment
152
Gaming
2
Government & Legislation
430
Healthcare
15
Healthcare & Life Sciences
375
Immigration
10
Insurance
76
Labor & Employment
134
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
78
Securities & Markets
154
Tax
78
Telecom & Technology
47
Trade & Sanctions
141
Transportation
91
Get alerts for "MINDSET PHARMA INC."
We'll email you when new changes match "MINDSET PHARMA INC.".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!